Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis: The PRIME Diagnostic Clinical Trial.
Ng ABCD, Asif A, Agarwal R, Panebianco V, Girometti R, Ghai S, Gómez-Gómez E, Budäus L, Barrett T, Radtke JP, Kesch C, De Cobelli F, Pham T, Taneja SS, Hu JC, Tewari A, Rodríguez Cabello MÁ, Dias AB, Mynderse LA, Borghi M, Boesen L, Singh P, Renard-Penna R, Leow JJ, Falkenbach F, Pecoraro M, Giannarini G, Perlis N, López-Ruiz D, Kastner C, Schimmöller L, Rossiter M, Nathan A, Khetrapal P, Chan VW, Haider A, Clarke CS, Punwani S, Brew-Graves C, Dickinson L, Mitra A, Brembilla G, Margolis DJA, Takwoingi Y, Emberton M, Allen C, Giganti F, Moore CM, Kasivisvanathan V; PRIME Study Group Collaborators.
Ng ABCD, et al. Among authors: leow jj.
JAMA. 2025 Oct 7;334(13):1170-1179. doi: 10.1001/jama.2025.13722.
JAMA. 2025.
PMID: 40928788
Clinical Trial.